Skip to content

TB-related immune reaction to HIV therapy occurs 20 months after TB treatment first started - is this a record?

A simpler, cheaper way to assess HIV-positive children’s health

Emergence of resistance mutations: a comparison between drug classes

TB transmission in healthcare settings and improving infection control

10% of new TB cases involve drug resistance

Most HIV-positive patients do as well as HIV-negative counterparts following surgery

CD4 cell loss in gut is not restored by HIV treatment, may have long-term consequences

GSK halts development of new PI, brecanavir

Atazanavir: genetic predictors for hyperbilirubinemia found